logo

Tag : utility risk

Differentiating Services

differentiating life science servicesSome types of offerings can be especially difficult for life science companies to effectively market. Services, in particular, seem to cause companies problems. Services are intangible. Many services are customized and lack a fixed set of features. Because of this, marketers need to be especially careful or else marketing messages can quickly become uncompelling. While the default differentiators for products are their features, services often cannot be defined in such a way. In the hands of a novice marketer, this often causes the message to devolve into little other than benefit claims. The lack of anything tangible causes many companies to give up message validation almost in its entirety. Messages often revolve around the vague and facile claims of a company being “experienced,” “knowledgeable” or “leading” and its services being “valuable” and “effective,” among other claims which offer no comparative advantage and are largely meaningless to a skeptical audience.

So how does one effectively market a service-based life science business? Like any other offering, it starts with a meaningful differentiation. Since the differentiation won’t lie in anything tangible, we need to look at things such as processes, specialization or people along with more obvious things such as proprietary intellectual property. Attribute analyses can be important in helping to identify positioning opportunities, but there will ultimately be a limited amount of meaningful attributes which the scientist-customers truly care about. The life science marketer must ensure that any value propositions are extensively validated to combat the inherent ambiguity (and therefore increased utility risk) of the intangible service. Every time you make a claim, think about how you could best substantiate that claim, then do it. Standard tools such as case studies and testimonials help as well, but more direct validation techniques should be used when possible and applicable. As always, educational content should be a core component of your marketing. In order to trust you to perform a service for them, the scientist-customer will have to accept that you have the requisite knowledge and experience. Unless your brand is very well known to the customer, you should display your knowledge through educational content.

Service companies often have difficult time differentiating their services and validating their messages, and sub-par demand generation is often a direct result of this. By focusing on differentiators and strong validation of claims to reduce the perceived risk in purchasing the service, life science service companies can greatly improve their rate of lead generation.

"Is your life science service company failing to meet your lead generation expectations or quotas? If so, it may be time to call BioBM. We’re familiar with many of the pitfalls of marketing life science services and have the full-spectrum experience necessary to build your CRO or other service company into a growing, well-respected brand. Contact us today."

Reduce the Risk in Buying

Life science marketers often hold many simultaneous viewpoints on why customers purchase products. Frequently, the attributed reasons include a hodgepodge of quality, price, ease of use, suitability for their application, adoption by others, various performance metrics and many other reasons that may be general or product-specific. All that gets a bit confusing, and is a bit over-defined if you ask me. I prefer to start from one attribute and then elucidate from there: life scientists make purchasing decisions based on risk.

Considering the scientist as a purchasing decision-maker, risk has two main components: financial and utility. Financial risk can be represented as price, although a more accurate representation is total cost of ownership (TCOO). If a product is very expensive, that makes the purchase more risky since there will be less resources to devote to other important endeavors and also since there are more sunk costs if the product doesn’t perform to the customer’s expectations. Utility risk pertains to the product ability to perform the functions that it is expected to by the customer. In other words, from a customer-centric standpoint: “In my particular application(s), how likely is this product to meet my expectations?”

The risk-based view can answer a question that leaves a lot of companies scratching their heads: why free samples are used so infrequently. It’s common for life science consumables companies, especially smaller companies, to give out free samples when a product is first launched in order to get people to try it. Most often, unless the brand is highly trusted, free samples fail their purpose and are left unused on the shelf. This is because giving away the product only serves to reduce one of the two main components of risk: financial risk. It does nothing to mitigate utility risk.

What life science tools and services companies should aim to do is reduce overall risk by lowering utility risk as much as possible such that financial risk does not need to be reduced and they therefore do not need to discount their product (or perhaps can raise the price on their product!) This gets to the heart of conveying value to the customer – that value should, as much as possible, be something that is experienced rather than something that is simply told. This becomes clear if you ask yourself: “What can we do to minimize utility risk?” Simply claiming that your product works would be pretty far down the list.

If you’re still not convinced, go out and ask a few scientists which of the following they would be more likely to purchase: 1) a product that claims to have better performance but you are unsure if it will work for you, or 2) a product that has lesser performance but you are certain it will work.

Performance metrics are undeniably important, and scientists have different reasons for purchasing different products. At the end of the day, the product with the lowest risk will be able to capture a greater market share than its competition.

"Looking for more insights on how your life science company can capture market share and accelerate revenue growth through improved marketing? Talk to BioBM. Our life science marketing experts can help your company identify opportunities, develop strategies to capitalize on them, and execute activities to capture value from them."